• ⌘ + K
  • Home
  • 0
    Inbox
Explore
  • Browse All
  • Health
  • FedCiv
  • Defense
  • Events
Work
  • Teaming Hub
  • Watchlists
  • Bookmarks
  • Notes
Research
  • Grants
    • Contracts
    • Vehicles
    • OTAs
    • OTIDVs
    • DLA DIBBS
    • SBIR/STTR
  • Agencies
  • NAICS
  • PSC
  • DOGE Tracker

Federal Contract Awards

13awards

Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.

Awardee
is
W1SXMKJPL8B5
Award ID
Description
Recipient
Total Value
Awarding Agency
Funding Agency
Set Aside
NAICS
PSC
Award Date
Start Date
End Date
75A50118F33002
IGF::OT::IGFCANGENE CORPORATION$452,864OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation ManufacturingAN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTSep 6, 2018Aug 29, 2018Jul 31, 2025
VA69D15F0089
VARIZIGCANGENE CORPORATION$3,495VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSOct 7, 2014Oct 7, 2014Feb 28, 2015
HHSO10033001T
IGF::OT::IGFCANGENE CORPORATION$63,304,735OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation ManufacturingAN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTSep 16, 2013Sep 16, 2013Sep 8, 2018
HHSD200201252242C
IGF::OT::IGF VACCINIA IMMUNE GLOBULIN (VIG) SMALLPOXCANGENE CORPORATION$102,035,440CENTERS FOR DISEASE CONTROL AND PREVENTIONCENTERS FOR DISEASE CONTROL AND PREVENTION—325414Biological Product (except Diagnostic) ManufacturingQ301MEDICAL- LABORATORY TESTINGSep 1, 2012Aug 9, 2012Aug 9, 2017
W81XWH12P0321
HEPTAVALENT EQUINE BOTULISM ANTITOXINCANGENE CORPORATION$576,641DEPT OF THE ARMYDEPT OF THE ARMY—5417116640LABORATORY EQUIPMENT AND SUPPLIESMay 31, 2012May 31, 2012Aug 17, 2012
W81XWH09P0733
HE-BAT CANGENE BB IND #12502CANGENE CORPORATION$407,500DEPT OF THE ARMYDEPT OF THE ARMY—325414Biological Product (except Diagnostic) Manufacturing6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIESAug 26, 2009Aug 25, 2009Jun 15, 2011
HHSO100200600009C
DRUGS AND BIOLOGICALSCANGENE CORPORATION$1,561,865OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325414Biological Product (except Diagnostic) Manufacturing6505DRUGS AND BIOLOGICALSJun 16, 2006Jun 16, 2006Sep 28, 2018
HHSO100200600017C
TAS::75 XXXX::TASCANGENE CORPORATION$594,219,525OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325414Biological Product (except Diagnostic) Manufacturing6505DRUGS AND BIOLOGICALSMay 30, 2006May 30, 2006Dec 31, 2027
HHSO100200500007C
ANTHRAX THERAPEUTICSCANGENE CORPORATION$160,848,139OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 23, 2005Sep 27, 2005Sep 30, 2023
00272200309D272330076
—CANGENE CORPORATION$0NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541990All Other Professional, Scientific, and Technical ServicesR499SUPPORT- PROFESSIONAL: OTHERSep 15, 2003Sep 15, 2003Oct 31, 2007
HHSD200200301010C
01010 CANGENECANGENE CORPORATION$329,170,241CENTERS FOR DISEASE CONTROL AND PREVENTIONCENTERS FOR DISEASE CONTROL AND PREVENTION—621511Medical Laboratories—Jan 23, 2003Jan 23, 2003Jul 21, 2015
HHSD2002002003570002
CANGENE, 200-2002-00357CANGENE CORPORATION$40,599,750CENTERS FOR DISEASE CONTROL AND PREVENTIONCENTERS FOR DISEASE CONTROL AND PREVENTION—621511Medical Laboratories—Jan 23, 2003Jan 23, 2003Aug 9, 2007
HHSD2002002003570001
CANGENE, 200-2002-00357CANGENE CORPORATION$40,599,750CENTERS FOR DISEASE CONTROL AND PREVENTIONCENTERS FOR DISEASE CONTROL AND PREVENTION—621511Medical Laboratories—Sep 11, 2002Sep 11, 2002Aug 9, 2007
Page 1 of 1
  • Previous
  • Next